Literature DB >> 25670654

A History of Treated Periprosthetic Joint Infection Increases the Risk of Subsequent Different Site Infection.

Hany Bedair1, Nitin Goyal, Mathew J Dietz, Kenneth Urish, Viktor Hansen, Jorge Manrique, William Hamilton, Greg Deirmengian.   

Abstract

BACKGROUND: After the successful treatment of periprosthetic joint infection (PJI), patients may present with degenerative joint disease in another joint with symptoms severe enough to warrant arthroplasty. However, it is not known whether patients with a history of treated PJI at one site will have an increased risk of PJI in the second arthroplasty site. QUESTIONS/PURPOSES: The primary objective of this study is to determine if there is a difference in the risk of developing a PJI after a second total hip arthroplasty (THA) or total knee arthroplasty (TKA) in patients who have had a previous PJI at another anatomic site compared with patients who have had no history of PJI. The secondary objective is to determine other potential risk factors that may predict PJI at the site of the second arthroplasty.
METHODS: A retrospective matched cohort study was performed to identify all patients at four academic institutions successfully treated for PJI who subsequently underwent a second primary THA or TKA (n = 90), constituting our study group. Patients were matched (one-to-one) to control subjects who had no history of PJI after their first arthroplasty (n = 90); they were matched based on age, sex, diabetic status, BMI, American Society of Anesthesiologists, institution, joint of interest, and year of surgery (± 2 years). We compared the case and control groups to determine whether a prior infection increased the relative risk of a subsequent PJI at another anatomic site. To identify other potential risk factors for subsequent PJI, a subgroup univariate analysis of our study group (n = 90) was performed. To identify other potential risk factors for subsequent PJI, a subgroup univariate analysis of our study group (n = 90) was performed.
RESULTS: Patients with a history of PJI had a greater risk of developing PJI in a subsequent THA or TKA (10 of 90 versus zero of 90 in the control group; relative risk, 21.00; 95% confidence interval [CI], 1.25-353.08; p = 0.035). Excluding PJI, we identified no other factors associated with a second joint infection. In patients with a history of PJI, a second PJI occurred more frequently in female patients (female: nine of 10 [90%] versus female: 40 of 80 [50%]; odds ratio [OR], 8.83; 95% CI, 1.13-403.33; p = 0.02) and in those whose initial infection was a staphylococcal species (subsequent PJI seven of 10 [70%] versus no subsequent PJI 28 of 80 [35%]; OR, 4.26; 95% CI, 0.89-27.50; p = 0.04).
CONCLUSIONS: A history of PJI predisposes patients to subsequent PJI in primary THA or THA. Patients and surgeons must be aware of the higher risk of this devastating complication before proceeding with a second arthroplasty. LEVEL OF EVIDENCE: Level III, prognostic study.

Entities:  

Mesh:

Year:  2015        PMID: 25670654      PMCID: PMC4457745          DOI: 10.1007/s11999-015-4174-4

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  12 in total

1.  The fate of the remaining knee(s) or hip(s) in osteoarthritic patients undergoing a primary TKA or THA.

Authors:  Yunchao Shao; Chi Zhang; Kory D Charron; Steven J Macdonald; Richard W McCalden; Robert B Bourne
Journal:  J Arthroplasty       Date:  2013-12       Impact factor: 4.757

2.  Recurrent periprosthetic joint infection: persistent or new infection?

Authors:  Benjamin Zmistowski; Matthew W Tetreault; Pouya Alijanipour; Antonia F Chen; Craig J Della Valle; Javad Parvizi
Journal:  J Arthroplasty       Date:  2013-04-12       Impact factor: 4.757

3.  Periprosthetic joint infection: are patients with multiple prosthetic joints at risk?

Authors:  S Mehdi Jafari; David S Casper; Camilo Restrepo; Benjamin Zmistowski; Javad Parvizi; Peter F Sharkey
Journal:  J Arthroplasty       Date:  2012-03-03       Impact factor: 4.757

4.  Is potential malnutrition associated with septic failure and acute infection after revision total joint arthroplasty?

Authors:  Paul H Yi; Rachel M Frank; Elliott Vann; Kevin A Sonn; Mario Moric; Craig J Della Valle
Journal:  Clin Orthop Relat Res       Date:  2015-01       Impact factor: 4.176

5.  The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost.

Authors:  James D Whitehouse; N Deborah Friedman; Kathryn B Kirkland; William J Richardson; Daniel J Sexton
Journal:  Infect Control Hosp Epidemiol       Date:  2002-04       Impact factor: 3.254

6.  Revision total knee arthroplasty infection: incidence and predictors.

Authors:  S M Javad Mortazavi; Justin Schwartzenberger; Matthew S Austin; James J Purtill; Javad Parvizi
Journal:  Clin Orthop Relat Res       Date:  2010-08       Impact factor: 4.176

7.  [Risk factors for infections of methicillin-resistant Staphylococci in diabetic foot patients].

Authors:  Qun Ding; Dai-qing Li; Peng-hua Wang; Yue-jie Chu; Shu-you Meng; Qian Sun
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2012-01-31

8.  Periprosthetic joint infection: the incidence, timing, and predisposing factors.

Authors:  Luis Pulido; Elie Ghanem; Ashish Joshi; James J Purtill; Javad Parvizi
Journal:  Clin Orthop Relat Res       Date:  2008-04-18       Impact factor: 4.176

9.  Mortality after septic versus aseptic revision total hip arthroplasty: a matched-cohort study.

Authors:  Ho-Rim Choi; Benjamin Beecher; Hany Bedair
Journal:  J Arthroplasty       Date:  2013-08-09       Impact factor: 4.757

10.  Metachronous infections in patients who have had more than one total joint arthroplasty.

Authors:  R P Murray; M H Bourne; R H Fitzgerald
Journal:  J Bone Joint Surg Am       Date:  1991-12       Impact factor: 5.284

View more
  9 in total

Review 1.  Osteomyelitis: Recent advances in pathophysiology and therapeutic strategies.

Authors:  Mitchell C Birt; David W Anderson; E Bruce Toby; Jinxi Wang
Journal:  J Orthop       Date:  2016-10-26

2.  CORR Insights®: Are Sonication Cultures of Antibiotic Cement Spacers Useful During Second-stage Reimplantation Surgery for Prosthetic Joint Infection?

Authors:  Carl A Deirmengian
Journal:  Clin Orthop Relat Res       Date:  2018-10       Impact factor: 4.176

3.  Familial Clustering Identified in Periprosthetic Joint Infection Following Primary Total Joint Arthroplasty: A Population-Based Cohort Study.

Authors:  Mike B Anderson; Karen Curtin; Jathine Wong; Christopher E Pelt; Christopher L Peters; Jeremy M Gililland
Journal:  J Bone Joint Surg Am       Date:  2017-06-07       Impact factor: 5.284

4.  Do Culture Negative Periprosthetic Joint Infections Remain Culture Negative?

Authors:  Beverly L Hersh; Neel B Shah; Scott D Rothenberger; Jason P Zlotnicki; Brian A Klatt; Kenneth L Urish
Journal:  J Arthroplasty       Date:  2019-06-28       Impact factor: 4.757

Review 5.  Multi-disciplinary antimicrobial strategies for improving orthopaedic implants to prevent prosthetic joint infections in hip and knee.

Authors:  Matthew A Getzlaf; Eric A Lewallen; Hilal M Kremers; Dakota L Jones; Carolina A Bonin; Amel Dudakovic; Roman Thaler; Robert C Cohen; David G Lewallen; Andre J van Wijnen
Journal:  J Orthop Res       Date:  2015-12-29       Impact factor: 3.494

6.  CORR Insights®: Low Reinfection Rates but a High Rate of Complications in THA for Infection Sequelae in Childhood: A Systematic Review.

Authors:  Carl A Deirmengian
Journal:  Clin Orthop Relat Res       Date:  2021-05-01       Impact factor: 4.176

Review 7.  Silver Nanocoating Technology in the Prevention of Prosthetic Joint Infection.

Authors:  Jiri Gallo; Ales Panacek; Robert Prucek; Eva Kriegova; Sarka Hradilova; Martin Hobza; Martin Holinka
Journal:  Materials (Basel)       Date:  2016-05-05       Impact factor: 3.623

8.  The influence of antibiotic-loaded cement spacers on the risk of reinfection after septic two-stage hip revision surgery.

Authors:  Kevin Staats; Florian Sevelda; Alexandra Kaider; Christoph Böhler; Irene K Sigmund; Stephan E Puchner; Reinhard Windhager; Johannes Holinka
Journal:  Infection       Date:  2017-10-24       Impact factor: 3.553

9.  Daptomycin-Tobramycin Cement Beads have Lethal Local Antibacterial Effect in Resistant Periprosthetic Joint Infections.

Authors:  Vivek Jagadale; Robert Achilike; Keith M Nord
Journal:  Cureus       Date:  2019-09-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.